SCHEMBL32681272

SCHEMBL32681272

CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ DPP3 Q9NY33 5/20 0.62
▸ NTSR2 O95665 1/20 0.60
▸ NTSR1 P30989 1/20 0.60
▸ SORT1 Q99523 1/20 0.60
▸ CAPN1 P07384 2/20 0.58
▸ CTSB P07858 2/20 0.58
▸ F13A1 P00488 1/20 0.53
▸ TGM2 P21980 1/20 0.53
▸ KISS1R Q969F8 1/20 0.53
▸ ECE1 P42892 4/20 0.51
▸ ITGB2 P05107 1/20 0.51
▸ ICAM1 P05362 1/20 0.51
▸ ITGAL P20701 1/20 0.51
▸ DPP4 P27487 1/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ KMT2A Q03164 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32681280 0.95 DPP3 (0.59) DPP3NTSR2NTSR1SORT1CAPN1
SCHEMBL30051283 0.94 DPP3 (0.61) DPP3NTSR2NTSR1SORT1CAPN1
SCHEMBL29713766 0.93 DPP3 (0.63) DPP3NTSR2NTSR1SORT1CAPN1
SCHEMBL30051839 0.92 DPP4 (0.54) DPP3NTSR2NTSR1SORT1CAPN1
SCHEMBL30442994 0.91 DPP3 (0.56) DPP3NTSR2NTSR1SORT1CAPN1
SCHEMBL30483549 0.91 DPP3 (0.58) DPP3NTSR2NTSR1SORT1CAPN1
SCHEMBL32681271 0.90 DPP3 (0.66) DPP3NTSR2NTSR1SORT1CAPN1
SCHEMBL31005883 0.90 KISS1R (0.57) DPP3NTSR2NTSR1SORT1CAPN1
SCHEMBL30288104 0.89 DPP3 (0.71) DPP3NTSR2NTSR1SORT1CAPN1
SCHEMBL30051252 0.89 DPP3 (0.65) DPP3NTSR2NTSR1SORT1CAPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260060913-A1 BIOACTIVE WALNUT PEPTIDES FOR TREATING HAIR LOSS L'OREAL (FR) 2026-03-05 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260060913-A1 BIOACTIVE WALNUT PEPTIDES FOR TREATING HAIR LOSS TYR, CUTA, ARGLU1 DPP3 1619/4885NTSR2 1629/4885NTSR1 1686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback